Improving prostate health in Black communities through community engagement
Official title: Building Community Living Labs (CoLLab) in Black Communities With the Goal of Advancing Prostate Health Equity and Reducing Prostate Cancer Disparities in Black Men
Run by Mayo Clinic · NCT06541210 · Data updated 2026-11-12
This study is testing a new program to help Black men get better access to prostate health services and screenings by comparing it to a regular setup at different community locations.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 80 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 1 site (Jacksonville, Florida) |
| Status | Recruiting |
| Started | May 4, 2024 |
| Main results expected | September 30, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT06541210 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Black men aged 30 to 80 residing in Jacksonville, FL, who are willing to participate and consent to the study.
✕Probably not a fit
Patients outside the age range of 30 to 80 or those not residing in the Jacksonville area may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to establish a Community Living Labs (CoLLab) Learning Health System to enhance access to prostate health services for Black men. The study will compare the impact of this system at three American Legion Posts against a control post without the CoLLab setup. Community health workers will facilitate education and access to prostate cancer screening and services, with the goal of improving health outcomes. Participants will engage with the CoLLab services at least twice a month for up to one year.
Why it matters
Potential benefit: If successful, this initiative could significantly improve prostate cancer screening and health outcomes for Black men.
How similar studies have gone: Other studies have shown success in using community health workers to improve health outcomes in underserved populations, indicating a promising approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * AIMS 1 AND 3: Participants must be one of the following key personnel: * Community PI (n=1), * CoLLab Program Manager (n=1) * CoLLab Site Managers (n=3) * CoLLab CAB members (n=21) * 2 Community Health Workers (CHWs) per Post site (n=6) * AIMS 1 AND 3: Between the ages of 21 and 80. * AIMS 1 AND 3: Able to complete the survey in English. * AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties. * AIMS 1 AND 3: Willing and able to consent to the study. * AIM 2: Black adult of any gender. * AIM 2: Must be between the ages of 30 and 80. * AIM 2: Able to speak English. * AIM 2: Reside in the Jacksonville, FL and/or surrounding counties. * AIM 2: Willing and able to consent to the study. Exclusion Criteria: * AIMS 1 AND 3: Younger than 21years or older than 80 years. * AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study. * AIM 2: Younger than 30 years or older than 80 years. * AIM 2: Not a resident of NE Florida. * AIM 2: Unwilling or unable to consent to the study.
Where it's running
-
Mayo Clinic in Florida
Jacksonville, Florida, United States Recruiting
Study contacts
- Principal investigator: Folakemi T. Odedina, Ph.D. — Mayo Clinic
- Study coordinator: Clinical Trials Referral Office
- Email: mayocliniccancerstudies@mayo.edu
- Phone: 855-776-0015
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding NK Cell Function in Prostate Cancer Across Races
This study tests whether natural killer (NK) cells behave differently in prostate cancer patients of diverse racial backgrounds by analyzing blood and tissue samples.
-
MRI or CT planning to guide high-dose-rate prostate brachytherapy
This trial tests whether adding an MRI to CT-based treatment planning for HDR prostate brachytherapy changes urinary side effects in men with localized prostate cancer.
-
Targeted Early Detection for Men at High Genetic Risk for Prostate Cancer
This study tests urinary biomarkers and PSA to see if they can improve early detection for men with a strong family or genetic risk for prostate cancer.
-
Urine and MRI approach to find aggressive prostate cancer early
This study tests whether a urine test called MPS2, paired with MRI, can better detect aggressive prostate cancer in men 50–75 at risk, possibly reducing unnecessary biopsies.
-
GET FIT Together: a socially enhanced exercise program for older men with prostate cancer
This program tests whether adding structured social support to supervised online exercise reduces cancer-related loneliness and improves mental and physical health in men 65 and older who have had prostate cancer.
-
Improved MRI methods to distinguish benign from cancerous pelvic findings
This test tries new deep-learning image-processing methods on MRI scans to get clearer images faster for adults scanned for prostate screening or suspected endometriosis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.